India’s Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn
In Phispers this week, Indian drugmaker Sun Pharmaceutical acquired Jersey-based Organon in an all-cash deal valued at about US...
Impressions : 1916
Novo targets MASH with up to US$ 5.2bn Akero buy; BMS acquires cell therapy developer Orbital for US$ 1.5 bn
In this week’s Phispers, Novo Nordisk and Bristol Myers Squibb (BMS) struck multi-billion-dollar acquisitions to expand t...
Impressions : 1216
White House sacks CDC director; FDA okays Ionis’ Dawnzera, first RNA-based preventive for hereditary angioedema
The Trump administration has fired US Centers for Disease Control and Prevention (CDC) Director Susan Monarez, post a policy di...
Impressions : 1490
AbbVie, Amgen, Thermo Fisher to invest in US manufacturing to avoid tariffs; Merck KGaA acquires SpringWorks for US$ 3.9 bn
Ever since US President Donald Trump has talked about a “major tariff” on drug imports coming “very shortly&r...
Impressions : 1149
FDA okays Vertex’s non-opioid painkiller, Supernus’ wearable device for Parkinson’s; Sanofi, GSK plan share buybacks
While the healthcare sector in the US was embroiled in political uncertainties over tariffs and key appointments, the country&r...
Impressions : 925
Novo’s parent buys Catalent for US$ 16.5 bn, Lilly calls for scrutiny; Novartis acquires MorphoSys
The Novo Nordisk-Eli Lilly rivalry over obesity drugs got intensified with Novo Nordisk’s parent company acquiring contra...
Impressions : 1519
Sanofi, Roche, Sobi, Avantor – a big week for M&As; JAK inhibitors to carry heart safety, cancer warnings
This week, Phispers brings you news on Pfizer’s Xeljanz, which underwent a post-approval study. Post the study, the ...
Impressions : 2250
Pfizer unveils new brand identity; EMA, FDA signal delay in conditional nod to AstraZeneca’s vaccine
The New Year opened with ample news from the world of pharmaceuticals.
Drug behemoth Pfizer unveiled a new brand identity whi...
Impressions : 1883
Novartis in crisis management mode; Elanco buys Bayer’s animal health business for US$ 7.6 billion
This week, Phispers updates you on the data manipulation at Novartis for its gene therapy Zolgensma.
The Swiss drugmaker is no...
Impressions : 4608
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.